Rise Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.15M Buy
4,542
+125
+3% +$29.1K 0.32% 30
2026
Q1
$1.08M Buy
4,417
+75
+2% +$17.5K 0.38% 23
2025
Q4
$899K Sell
4,342
-175
-4% -$34.6K 0.32% 28
2025
Q3
$838K Buy
4,517
+173
+4% +$29.6K 0.3% 27
2025
Q2
$664K Sell
4,344
-121
-3% -$18.6K 0.26% 32
2025
Q1
$740K Buy
4,465
+1,367
+44% +$214K 0.33% 26
2024
Q4
$448K Sell
3,098
-36
-1% -$5.58K 0.22% 48
2024
Q3
$508K Buy
3,134
+96
+3% +$15.3K 0.24% 42
2024
Q2
$444K Buy
3,038
+94
+3% +$14K 0.24% 44
2024
Q1
$466K Buy
2,944
+1,137
+63% +$181K 0.25% 40
2023
Q4
$283K Buy
1,807
+441
+32% +$67.6K 0.2% 51
2023
Q3
$213K Sell
1,366
-9
-0.7% -$1.49K 0.17% 57
2023
Q2
$228K Sell
1,375
-96
-7% -$15.5K 0.18% 60
2023
Q1
$228K Buy
1,471
+19
+1% +$3.07K 0.17% 57
2022
Q4
$257K Sell
1,452
-376
-21% -$64.9K 0.21% 54
2022
Q3
$299K Buy
1,828
+384
+27% +$65K 0.25% 48
2022
Q2
$256K Buy
1,444
+9
+0.6% +$1.6K 0.26% 52
2022
Q1
$254K Sell
1,435
-50
-3% -$8.51K 0.23% 58
2021
Q4
$254K Buy
+1,485
New +$243K 0.24% 55

Other funds holding JNJ

Rise Advisors's JNJ Position: Q2 2026 in Review

Rise Advisors increased its Johnson & Johnson (JNJ) stake by 2.8% in Q2 2026, buying an estimated $29.1K and bringing the position to 4,542 shares worth $1.15M. The position accounts for 0.32% of the portfolio, ranked #30.

Rise Advisors first reported a position in JNJ in Q4 2021 and has held it in 19 quarters since. 899 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Rise Advisors held 4,542 shares of Johnson & Johnson worth $1.15M as of Q2 2026.
  • Rise Advisors bought 125 Johnson & Johnson shares in Q2 2026, an estimated $29.1K.
  • Johnson & Johnson made up 0.32% of Rise Advisors's portfolio in Q2 2026, its #30 holding.
  • Rise Advisors first reported a position in Johnson & Johnson in Q4 2021 and has held it in 19 quarters since.
  • 899 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Rise Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.